Knowledge is power.
The Kellis IP Weekly
Since living in Brazil from 2021-2024 as the USPTO’s Intellectual Property Attaché for Brazil, Argentina, Paraguay, Uruguay, Guyana, and Suriname, Mr. Kellis has published the Kellis IP Weekly to help interested parties stay informed regarding intellectual property developments in Brazil and the surrounding region. If you have questions or concerns about any of the developments described in the Kellis IP Weekly and how those developments might impact your business, please contact Kellis IP.
Search the Kellis IP Weekly
The Kellis IP Weekly: Issue 10.5
INPI Releases Study on Patenting Scenario Surrounding Monoclonal Antibodies for Breast Cancer Treatment: The study, coordinated by INPI and conducted by the Technical Group for Intelligence in Industrial Property under the Interministerial Group for Intellectual Property (GIPI), evaluates patent applications related to the monoclonal antibodies trastuzumab and pertuzumab (which are costly for Brazil’s universal health system, SUS, to acquire) . . .
Click below to read more and see additional headlines.
The Kellis IP Weekly: Issue 9.4
New AI Bill Text Expected: Since the most recent version of PL 2338/23 was released on July 4, 2024, legislators have submitted an additional 15 proposed amendments to that bill and received input and feedback from dozens of entities. Rapporteur Eduardo Gomes is expected to soon release an updated version of the text, which will reveal . . .
Click below to see more headlines.
The Kellis IP Weekly: Issue 9.2
INPI Publishes Latest Performance Results: INPI has updated its online reporting system with the latest data, from August 2024. According to that system, the average patent pendency is . . .
Click below to see more headlines.
The Kellis IP Weekly: Issue 9.1
INPI Announces Anti-Counterfeiting Directory for GIs: INPI’s National Directory for Combatting Counterfeiting, which previously contained information pertinent only to trademarks, has been expanded to include GI-related information. GI owners may now include . . .
Click below to see more headlines.
The Kellis IP Weekly: Issue 8.5
INPI Gives Some Patent Owners 60 Days to Provide Information about Access to Genetic Resources: INPI’s August 27 Industrial Property Gazette contains a public notice explaining that in some cases, INPI has issued patents to applicants who affirmed that the subject invention utilized access to genetic resources, but never provided the corresponding SisGen registration number as required . . .
Click below to see more headlines.